Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1103
-
Total 13F shares, excl. options
-
226M
-
Shares change
-
-11.5M
-
Total reported value, excl. options
-
$19.7B
-
Value change
-
-$1B
-
Put/Call ratio
-
0.64
-
Number of buys
-
396
-
Number of sells
-
-525
-
Price
-
$86.96
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q3 2020
1,217 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q3 2020.
NOVARTIS AG - Ordinary Shares (NVS) has 1,103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 226M shares
of 2.18B outstanding shares and own 10.36% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (22.6M shares), Dodge & Cox (21.8M shares), LOOMIS SAYLES & CO L P (10.5M shares), Fisher Asset Management, LLC (9.06M shares), Mawer Investment Management Ltd. (8.52M shares), FRANKLIN RESOURCES INC (8.33M shares), BANK OF AMERICA CORP /DE/ (8.1M shares), Aristotle Capital Management, LLC (6.76M shares), RENAISSANCE TECHNOLOGIES LLC (6.68M shares), and UBS Group AG (6.65M shares).
This table shows the top 1103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.